We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Assura plc (AGR) Ord Shs GBP0.10

Sell:66.90p Buy:66.95p 0 Change: 2.20p (3.19%)
FTSE 250:1.61%
Market closed Prices as at close on 29 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:66.90p
Buy:66.95p
Change: 2.20p (3.19%)
Market closed Prices as at close on 29 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:66.90p
Buy:66.95p
Change: 2.20p (3.19%)
Market closed Prices as at close on 29 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Assura plc is a United Kingdom-based real estate investment trust (REIT). The Company specializes in the development of, investment in and management of, a portfolio of primary care, community, diagnostic and treatment buildings across the United Kingdom. It develops new buildings, invests in existing buildings, manages its portfolio, and owns them for the long term. Its primary care estate accommodates a range of NHS services in communities, from general practice to diagnostic and treatment services including x-ray, renal dialysis and MSK physiotherapy; dentistry; acute consultant clinics and other community and social prescribing services. The Company is a long-term property partner to more than 600 medical centers. The Company owns and manages a portfolio of about 645 properties. Its subsidiaries include Assura (SC1) Ltd, Assura Development Hub Ltd, Assura Primary Care Properties Ltd, Apollo Capital Projects Development Ltd, and Upton Community Health Care Ltd, among others.

Contact details

Address:
The Brew House, Greenalls Avenue
WARRINGTON
WA4 6HL
United Kingdom
Telephone:
+44 (01925) 420660
Website:
https://www.assuraplc.com/

Important dates

Future events
Quarterly dividend payment date 13 July 2022 13/07/22
AGM 06 July 2022 06/07/22
Past events
Quarterly ex-dividend date 09 June 2022 09/06/22
Annual report 01 June 2022 01/06/22
Final results 24 May 2022 24/05/22
Final results 18 May 2022 18/05/22
Quarterly dividend payment date 13 April 2022 13/04/22
Trading Announcement 01 April 2022 01/04/22
Quarterly ex-dividend date 10 March 2022 10/03/22
Quarterly dividend payment date 12 January 2022 12/01/22
Trading Announcement 10 January 2022 10/01/22
Quarterly ex-dividend date 09 December 2021 09/12/21
Interim results 11 November 2021 11/11/21
Quarterly dividend payment date 13 October 2021 13/10/21
Trading Announcement 05 October 2021 05/10/21
Quarterly ex-dividend date 09 September 2021 09/09/21
Quarterly dividend payment date 14 July 2021 14/07/21
Trading Announcement 06 July 2021 06/07/21
AGM 06 July 2021 06/07/21

General stock information

EPIC:
AGR
ISIN:
GB00BVGBWW93
Market cap:
£1.97 billion
Shares in issue:
2.96 billion
Sector:
Real Estate Investment Trusts
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE 250,FTSE 350,FTSE All Share,FTSE 350 Higher Yield

Key personnel

  • Jonathan Murphy
    Chief Executive Officer, Executive Director
  • Jayne Cottam
    Chief Financial Officer, Executive Director
  • Orla Ball
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.